However, while many studies have heralded the drugs benefits for metabolic issues linked to diabetes, many researchers have cautioned that there are potentially serious health risks as well, such as severe gastrointestinal problems, stomach paralysis and intestinal blockages, which some critics indicate has not been adequately disclosed on the drug labels
The clinical case for pairing these medications with nutrition support is written into the label
In contrast, NAFL is diagnosed in the absence of ballooning or fibrosis and carries a relatively lower risk of liver-related morbidity [3]
Contraindicaciones El orlistat no debe ser usado por nios, mujeres embarazadas o en perodo de lactancia
2026, 13 state Medicaid programs cover GLP-1s for obesity treatment, according to an annual KFF survey.